MCM
Marathon Capital Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-102,241
| Closed | -$4.45M | – | 158 |
|
2022
Q2 | $4.45M | Sell |
102,241
-2,485
| -2% | -$108K | 1.44% | 13 |
|
2022
Q1 | $4.56M | Sell |
104,726
-419
| -0.4% | -$18.3K | 1.31% | 18 |
|
2021
Q4 | $4.64M | Sell |
105,145
-756
| -0.7% | -$33.3K | 1.09% | 15 |
|
2021
Q3 | $4.05M | Buy |
105,901
+113
| +0.1% | +$4.32K | 0.92% | 19 |
|
2021
Q2 | $4.21M | Sell |
105,788
-314
| -0.3% | -$12.5K | 0.98% | 18 |
|
2021
Q1 | $3.79M | Buy |
106,102
+5,183
| +5% | +$185K | 1% | 21 |
|
2020
Q4 | $3.71M | Sell |
100,919
-12,491
| -11% | -$460K | 1.09% | 17 |
|
2020
Q3 | $4.27M | Sell |
113,410
-4,278
| -4% | -$161K | 1.55% | 5 |
|
2020
Q2 | $4.8M | Buy |
117,688
+42,300
| +56% | +$1.73M | 1.84% | 3 |
|
2020
Q1 | $2.86M | Sell |
75,388
-244
| -0.3% | -$9.24K | 1.31% | 9 |
|
2019
Q4 | $3.55M | Buy |
75,632
+4,634
| +7% | +$218K | 1.21% | 7 |
|
2019
Q3 | $3.03M | Buy |
70,998
+106
| +0.1% | +$4.52K | 1.22% | 7 |
|
2019
Q2 | $2.84M | Sell |
70,892
-655
| -0.9% | -$26.2K | 1.16% | 9 |
|
2019
Q1 | $2.99M | Sell |
71,547
-1,044
| -1% | -$43.6K | 1.34% | 6 |
|
2018
Q4 | $2.77M | Sell |
72,591
-5,825
| -7% | -$223K | 1.38% | 5 |
|
2018
Q3 | $3.15M | Sell |
78,416
-1,265
| -2% | -$50.8K | 1.22% | 8 |
|
2018
Q2 | $3.21M | Buy |
79,681
+337
| +0.4% | +$13.6K | 1.21% | 4 |
|
2018
Q1 | $3.1M | Buy |
79,344
+10,310
| +15% | +$403K | 1.21% | 7 |
|
2017
Q4 | $2.45M | Sell |
69,034
-351
| -0.5% | -$12.4K | 0.96% | 17 |
|
2017
Q3 | $2.82M | Buy |
69,385
+25
| +0% | +$1.02K | 1.19% | 13 |
|
2017
Q2 | $2.99M | Buy |
69,360
+450
| +0.7% | +$19.4K | 1.41% | 11 |
|
2017
Q1 | $2.91M | Buy |
68,910
+395
| +0.6% | +$16.7K | 1.44% | 11 |
|
2016
Q4 | $2.64M | Buy |
68,515
+54,920
| +404% | +$2.11M | 1.26% | 10 |
|
2016
Q3 | $586K | Buy |
+13,595
| New | +$586K | 0.29% | 44 |
|